Skip to main content
. 2012 Oct-Dec;24(4):369–374. doi: 10.1590/S0103-507X2012000400013

Table 2.

Outcomes of the placebo and 2% chlorhexidine/toothbrushing groups

Variables Placebo N(%) Chlorhexidine N(%) p value
VAP rate 11(45.8) 18(64.3) 0.29
Microbiologically confirmed VAP rate 8(72.7) 12(66.6) 0.86
Duration of intubation (days) 6 [4-12.7] 8.5 [7.3-14.7] 0.17
Duration of intubation      
     Between 3 and 5 days 12(50) 5(17.8) 0.03
  Between 6 and 10 days 5(20.8) 14(50.0) 0.06
  >10 days 9(29.2) 7(32.2) 0.94
Duration of ICU stay (days) 11 [5-16] 12 [9-29] 0.36
Duration of hospital stay (days) 17 [11-23] 19 [9-34] 0.62
Mortality rate 9(37.5) 13(46.5) 0.07

VAP - ventilator-associated pneumonia; ICU - Intensive care unit. Results are expressed as the number (%) or median [25%-75%].